Company Filing History:
Years Active: 2008
Title: Eric W F W Alton: Innovator in Gene Therapy
Introduction
Eric W F W Alton is a prominent inventor based in London, GB. He has made significant contributions to the field of gene therapy, particularly in the development of vectors for gene transfer. His innovative work aims to address critical health issues, including cystic fibrosis.
Latest Patents
Alton holds a patent for a recombinant Sendai virus vector designed for introducing exogenous genes to airway epithelia. This patent outlines a method for efficiently transferring genes to native mucus-layered airway epithelial cells. The recombinant Sendai virus vector allows for gene introduction not only to apical surfaces but also to submucosal glands, where CFTR primarily expresses. This technology holds promise for gene therapy in treating cystic fibrosis, a disease caused by CFTR deficiency.
Career Highlights
Alton is associated with Dna Vec Research Inc., where he continues to advance his research in gene therapy. His work has garnered attention for its potential to revolutionize treatment options for respiratory diseases.
Collaborations
He has collaborated with notable colleagues, including Yoshikazu Yonemitsu and Mamoru Hasegawa, to further enhance the impact of his research in the field.
Conclusion
Eric W F W Alton's innovative contributions to gene therapy exemplify the potential of recombinant vectors in medical science. His work continues to inspire advancements in the treatment of genetic disorders.